Early-onset Pauciarticular Juvenile Rheumatoid Arthritis Associated with Human Leukocyte Antigen-DRw5, Iritis, and Antinuclear Antibody
Overview
Affiliations
Evidence has been sought for a genetically determined predisposition among children with juvenile rheumatoid arthritis (JRA) who are also at particular risk for the development of inflammatory eye disease.45 unrelated Caucasian patients (41 female) with early-onset pauciarticular JRA were human leukocyte antigen (HLA) types. 28 of the study group were found to be HLA-DRw5 compared with 16 of 84 controls (X(2), 24.3, P = <0.001). 9 patients were HLA-DRw8 compared with 4 of 84 controls (X(2), 7.51, P = <0.01). Iritis developed in 24 of the 45 children studied, 17 of whom were typed as HLA-DRw5 when compared to controls (X(2), 26.76, P = <0.001) and 6 with iritis typed as HLA-DRw8 (X(2), 9.10, P = <0.01). Antinuclear antibody was found in the serum of 17 of the 28 patients typing as HLA-DRw5 compared with 4 of the 17 who did not have this antigen (X(2), 5.88, P = <0.02). No such association was seen in patients with HLA-DRw8. In a study of linked genes, a delta value of 0.090 was found for HLA-DRw5 with HLA-B12, of 0.070 for DRw5 with HLA-Cw4, and a value of 0.050 for DRw5 and HLA-Bw35. This suggests a linkage disequilibrium between HLA-DRw5 and these two B series alleles, a conclusion which was supported by haplotype analysis in families of 11 of the disease probands. HLA-DRw5 has not previously been reported to be increased in any rheumatic disease group. It is proposed that HLA-DRw5 is a genetic marker defining those at risk for early-onset pauciarticular JRA with iritis.
Nigrovic P, Martinez-Bonet M, Thompson S Curr Opin Rheumatol. 2019; 31(5):401-410.
PMID: 31169548 PMC: 6800096. DOI: 10.1097/BOR.0000000000000637.
Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C Ann Rheum Dis. 2018; 77(8):1107-1117.
PMID: 29592918 PMC: 6059050. DOI: 10.1136/annrheumdis-2018-213131.
Angeles-Han S, Rabinovich C Curr Opin Rheumatol. 2016; 28(5):544-9.
PMID: 27328333 PMC: 4965315. DOI: 10.1097/BOR.0000000000000316.
Angeles-Han S, McCracken C, Yeh S, Jang S, Jenkins K, Cope S Invest Ophthalmol Vis Sci. 2015; 56(10):6043-8.
PMID: 26393471 PMC: 4585534. DOI: 10.1167/iovs.15-17168.
Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.
Angeles-Han S, Yeh S, Vogler L Int J Clin Rheumtol. 2013; 8(1).
PMID: 24187594 PMC: 3810987. DOI: 10.2217/ijr.12.83.